In gastric cancer, gastric cancer-derived mesenchymal stem cells (GC-MSCs) produce IL-6, which, through the IL-6-STAT3-extracellular signal-regulated kinase (ERK)1/2 pathway, steers neutrophils toward the N2 phenotype[24]. Here, STAT3 is linked to gastric cancer.